ENTERA BIO LTD. Lease Commitments For Shortterm Leases For Which Recognition Exemption Has Been Used
ENTERA BIO LTD. (ENTX) had Lease Commitments For Shortterm Leases For Which Recognition Exemption Has Been Used of $210.00 thousand as of 2018-12-31, per its 20-F filed 2019-03-28.
Discontinued › Notes › Leases
ifrs-full:LeaseCommitmentsForShorttermLeasesForWhichRecognitionExemptionHasBeenUsed · last filed 2019-03-28
- 2018-12-31: Lease Commitments For Shortterm Leases For Which Recognition Exemption Has Been Used $210.00K.
| Period end | Lease Commitments For Shortterm Leases For Which Recognition Exemption Has Been Used |
|---|---|
| 2018-12-31 | $210.00K 20-F · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |